Global hemostasis/coagulation analyzer market is estimated to be valued at USD 4.36 Bn in 2024 and is expected to exhibit a CAGR of 5.8% during the forecast period (2024-2031). The hemostasis/coagulation analyzer market has been growing at a steady rate over the past few years owing to the rising prevalence of blood disorders and increasing number of surgical procedures performed annually. Hemostasis analyzers help in coagulation testing and screening of various hematological conditions. Technological advancements in these devices have improved efficacy and efficiency of coagulation testing. The adoption of fully automated, high-throughput instruments allows processing of large number of samples simultaneously. However, high costs of advanced analyzers remain a factor limiting widespread adoption.
Market Dynamics:
The global hemostasis/coagulation analyzer market growth is driven by the rising incidence of coagulation disorders, increasing elderly population vulnerable to coagulation issues, and growing number of surgical procedures performed worldwide. However, high costs of analyzers remain a major restraint for the market. Ongoing developments in microfluidics technology provide opportunities for novel point-of-care testing devices with improved portability and miniaturized design. Integration of artificial intelligence aids automation and data interpretation, addressing the shortage of pathologists and improving turnaround times.
Key Features of the Study:
- This report provides an in-depth analysis of the global hemostasis/coagulation analyzer market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global hemostasis/coagulation analyzer market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study Horiba Medical, Siemens Healthineers AG, Agappe Diagnostics Ltd, NIHON KOHDEN CORPORATION, Sysmex Corporation, F. Hoffmann-La Roche Ltd, Stago Group, Maccura Biotechnology Co., Ltd., Thermo Fisher Scientific Inc., Haemonetics Corporation, Genrui Biotech Co., Ltd., BIOLABO S.A.S, Erba Mannheim, Sclavo Diagnostics International, and Helena Laboratories Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global hemostasis/coagulation analyzer market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemostasis/coagulation analyzer market.
Detailed Segmentation-
- By Product:
- Clinical Laboratory Analyzers
- Reagents
- Systems
- Point-of-care Testing Analyzers
- By Test:
- Prothrombin Time Testing
- Fibrinogen Testing
- Activated Clotting Time Testing
- Platelet Function Tests
- Anti-Factor XA Tests
- Others
- By Technology:
- Optical
- Mechanical
- Electrochemical
- Others
- By End User:
- Clinical Laboratories
- Hospitals
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Horiba Medical
- Siemens Healthineers AG
- Agappe Diagnostics Ltd
- NIHON KOHDEN CORPORATION
- Sysmex Corporation
- Hoffmann-La Roche Ltd
- Stago Group
- Maccura Biotechnology Co., Ltd.
- Thermo Fisher Scientific Inc.
- Haemonetics Corporation
- Genrui Biotech Co., Ltd.
- BIOLABO S.A.S
- Erba Mannheim
- Sclavo Diagnostics International
- Helena Laboratories Corporation
